{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:29:32Z","timestamp":1788827372975,"version":"build-2803163510"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Significant advances have been made in detecting RNA markers that may indicate malignancy in fine needle aspiration cytology (FNAC) samples.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To review the roles of protein-coding and non-coding RNAs in differentiating between malignant and benign thyroid nodules.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A comprehensive literature search using PubMed, Science Direct, Web of Science, and SCOPUS databases was performed. We searched up until September 2024 and complemented by manual citation search.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 28 full-text articles were reviewed, encompassing 5770 FNAC samples, which included 3489 benign lesions and 2281 malignant lesions. The studies identified 43 messenger RNAs (mRNAs), 16 microRNAs (miRNAs), and 3 long non-coding RNAs (lncRNAs) that have the potential to distinguish malignant nodules. Among the mRNAs, <jats:italic>PAPPA<\/jats:italic>, <jats:italic>TIMP1<\/jats:italic>, and <jats:italic>HMGA2<\/jats:italic>, as well as the miRNAs, miR-146b, miR-375 and miR-222, appear to be the most promising molecules for diagnosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Numerous RNA markers have been shown to differentiate malignant from benign lesions. However, there is still a lack of patient-specific classification for thyroid cancer subtypes. Additionally, future studies should prioritize using a combination of molecular markers rather than relying on individual ones. Although current research mainly focuses on identifying cancer-specific molecules, it is important for future studies to shift towards a more patient-specific approach.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s12020-025-04266-z","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T11:01:50Z","timestamp":1746788510000},"page":"365-379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A systematic review of emerging RNA markers in thyroid fine needle aspiration cytology samples: advancements and challenges"],"prefix":"10.1007","volume":"89","author":[{"given":"Gamze","family":"S\u00f6nmez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5054-1396","authenticated-orcid":false,"given":"U\u011fur","family":"\u00dcnl\u00fct\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"4266_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S2213-8587(22)00101-2","volume":"10","author":"EK Alexander","year":"2022","unstructured":"E.K. Alexander, E.S. Cibas, Diagnosis of thyroid nodules. Lancet Diabetes Endocrinol. 10, 533\u2013539 (2022).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4266_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.2174\/138920211798120781","volume":"12","author":"JM Cerutti","year":"2011","unstructured":"J.M. Cerutti, Employing genetic markers to improve diagnosis of thyroid tumor fine needle biopsy. Curr. Genomics 12, 589\u2013596 (2011).","journal-title":"Curr. Genomics"},{"key":"4266_CR3","first-page":"1039","volume":"33","author":"SZ Ali","year":"2023","unstructured":"S.Z. Ali et al., The 2023 bethesda system for reporting thyroid cytopathology. Thyroid 33, 1039\u20131044 (2023).","journal-title":"Thyroid"},{"key":"4266_CR4","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.2147\/CMAR.S304686","volume":"13","author":"K Kaliszewski","year":"2021","unstructured":"K. Kaliszewski et al., The correlation of age with prognosis of atypia of undetermined significance and follicular lesion of undetermined significance in thyroid nodules. Cancer Manag. Res. 13, 3101\u20133111 (2021).","journal-title":"Cancer Manag. Res."},{"key":"4266_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11154-023-09842-0","volume":"25","author":"C Ferraz","year":"2024","unstructured":"C. Ferraz, Molecular testing for thyroid nodules: where are we now?. Rev. Endocr. Metab. Disord. 25, 149\u2013159 (2024).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"4266_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"P Whiting","year":"2011","unstructured":"P. Whiting et al., QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann. Intern. Med. 155, 529\u201336 (2011).","journal-title":"Ann. Intern. Med."},{"key":"4266_CR7","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3389\/fgene.2019.00496","volume":"10","author":"J Li","year":"2019","unstructured":"J. Li, C. Liu, Coding or noncoding, the converging concepts of RNAs. Front. Genet. 10, 496 (2019).","journal-title":"Front. Genet."},{"key":"4266_CR8","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1089\/thy.2016.0285","volume":"27","author":"P Weinberger","year":"2017","unstructured":"P. Weinberger et al., Cell cycle M-phase genes are highly upregulated in anaplastic thyroid carcinoma. Thyroid 27, 236\u2013252 (2017).","journal-title":"Thyroid"},{"key":"4266_CR9","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.1038\/onc.2012.399","volume":"32","author":"R Koyama-Nasu","year":"2013","unstructured":"R. Koyama-Nasu et al., The critical role of cyclin D2 in cell cycle progression and tumorigenicity of glioblastoma stem cells. Oncogene 32, 3840\u20133845 (2013).","journal-title":"Oncogene"},{"key":"4266_CR10","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.4161\/cc.9.7.11126","volume":"9","author":"Y Huang","year":"2010","unstructured":"Y. Huang et al., Pituitary homeobox 2 (PITX2) promotes thyroid carcinogenesis by activation of cyclin D2. Cell Cycle 9, 1333\u20131341 (2010).","journal-title":"Cell Cycle"},{"key":"4266_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12957-023-02899-w","volume":"21","author":"SF Yuan","year":"2023","unstructured":"S.F. Yuan et al., CCND2 and miR-206 as potential biomarkers in the clinical diagnosis of thyroid carcinoma by fine-needle aspiration cytology. World J. Surg. Oncol. 21, 22 (2023).","journal-title":"World J. Surg. Oncol."},{"key":"4266_CR12","first-page":"4167","volume":"63","author":"Y Okamoto","year":"2003","unstructured":"Y. Okamoto et al., UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme. Cancer Res. 63, 4167\u20134173 (2003).","journal-title":"Cancer Res."},{"key":"4266_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/cncy.20046","volume":"118","author":"E Guerriero","year":"2010","unstructured":"E. Guerriero et al., UbcH10 expression on thyroid fine-needle aspirates. Cancer Cytopathol. 118, 157\u2013165 (2010).","journal-title":"Cancer Cytopathol."},{"key":"4266_CR14","doi-asserted-by":"publisher","first-page":"x170","DOI":"10.1093\/annonc\/mdx678.003","volume":"28","author":"L Lim","year":"2017","unstructured":"L. Lim et al., PAPP-A is a marker of aggressive breast cancer and promotes cancer progression in-vitro. Ann. Oncol. 28, x170 (2017).","journal-title":"Ann. Oncol."},{"key":"4266_CR15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s40618-021-01655-9","volume":"45","author":"C Marzocchi","year":"2022","unstructured":"C. Marzocchi et al., Pregnancy-associated plasma protein A mRNA expression as a marker for differentiated thyroid cancer: results from a \u201csurgical\u201d and a \u201ccytological\u201d series. J. Endocrinol. Invest. 45, 369\u2013378 (2022).","journal-title":"J. Endocrinol. Invest."},{"key":"4266_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36922-1","volume":"14","author":"V Veschi","year":"2023","unstructured":"V. Veschi et al., Recapitulating thyroid cancer histotypes through engineering embryonic stem cells. Nat. Commun. 14, 1351 (2023).","journal-title":"Nat. Commun."},{"key":"4266_CR17","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/dc.24816","volume":"49","author":"I Dimitrova","year":"2021","unstructured":"I. Dimitrova et al., Increased gene expression of TIMP1 and CHI3L1 in fine-needle aspiration biopsy samples from papillary thyroid cancer as compared to benign nodules. Diagn. Cytopathol. 49, 1045\u20131051 (2021).","journal-title":"Diagn. Cytopathol."},{"key":"4266_CR18","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.21037\/gs.2018.11.04","volume":"8","author":"SM Sadowski","year":"2019","unstructured":"S.M. Sadowski et al., Validation of molecular biomarkers for preoperative diagnostics of human papillary thyroid carcinoma in fine needle aspirates. Gland. Surg. 8, S62 (2019).","journal-title":"Gland. Surg."},{"key":"4266_CR19","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.surg.2010.09.025","volume":"148","author":"A Mathur","year":"2010","unstructured":"A. Mathur et al., A prospective study evaluating the accuracy of using combined clinical factors and candidate diagnostic markers to refine the accuracy of thyroid fine needle aspiration biopsy. Surgery 148, 1170\u20131176 (2010).","journal-title":"Surgery"},{"key":"4266_CR20","doi-asserted-by":"publisher","first-page":"490","DOI":"10.2353\/jmoldx.2006.060080","volume":"8","author":"CC Lubitz","year":"2006","unstructured":"C.C. Lubitz et al., Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesions. J. Mol. Diagn. 8, 490\u2013498 (2006).","journal-title":"J. Mol. Diagn."},{"key":"4266_CR21","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1210\/er.2002-0008","volume":"24","author":"H Turner","year":"2003","unstructured":"H. Turner et al., Angiogenesis in endocrine tumors. Endocr. Rev. 24, 600\u2013632 (2003).","journal-title":"Endocr. Rev."},{"key":"4266_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-023-01131-9","volume":"56","author":"JE Yu","year":"2024","unstructured":"J.E. Yu et al., Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer. Exp. Mol. Med. 56, 1\u201318 (2024).","journal-title":"Exp. Mol. Med."},{"key":"4266_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3233\/CBM-160255","volume":"18","author":"D Luo","year":"2017","unstructured":"D. Luo et al., CHI3L1 overexpression is associated with metastasis and is an indicator of poor prognosis in papillary thyroid carcinoma. Cancer Biomark. 18, 273\u2013284 (2017).","journal-title":"Cancer Biomark."},{"key":"4266_CR24","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrc2894","volume":"10","author":"H Huang","year":"2010","unstructured":"H. Huang et al., Targeting the ANGPT-TIE2 pathway in malignancy. Nat. Rev. Cancer 10, 575\u2013585 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"4266_CR25","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nature09002","volume":"465","author":"Y Wang","year":"2010","unstructured":"Y. Wang et al., Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465, 483\u2013U108 (2010).","journal-title":"Nature"},{"key":"4266_CR26","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s12276-023-00975-5","volume":"55","author":"S Kim","year":"2023","unstructured":"S. Kim, TMPRSS4, a type II transmembrane serine protease, as a potential therapeutic target in cancer. Exp. Mol. Med. 55, 716\u2013724 (2023).","journal-title":"Exp. Mol. Med."},{"key":"4266_CR27","doi-asserted-by":"publisher","first-page":"101997","DOI":"10.1016\/j.tice.2022.101997","volume":"80","author":"J Chen","year":"2023","unstructured":"J. Chen et al., SLP-2 regulates the generation of reactive oxygen species and the ERK pathway to promote papillary thyroid carcinoma motility and angiogenesis. Tiss. Cell. 80, 101997 (2023).","journal-title":"Tiss. Cell."},{"key":"4266_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/apm.12505","volume":"124","author":"A Bartolome","year":"2016","unstructured":"A. Bartolome et al., Stomatin-like protein 2 overexpression in papillary thyroid carcinoma is significantly associated with high-risk clinicopathological parameters and BRAFV600E mutation. APMIS 124, 271\u2013277 (2016).","journal-title":"APMIS"},{"key":"4266_CR29","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1007\/s00405-018-5045-x","volume":"275","author":"XY Yang","year":"2018","unstructured":"X.Y. Yang et al., The diagnostic value of TROP-2, SLP-2 and CD56 expression in papillary thyroid carcinoma. Eur. Arch. Otorhinolaryngol. 275, 2127\u20132134 (2018).","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"4266_CR30","doi-asserted-by":"publisher","first-page":"15011","DOI":"10.3390\/ijms150915011","volume":"15","author":"X Gai","year":"2014","unstructured":"X. Gai et al., MRC2 expression correlates with TGF\u03b21 and survival in hepatocellular carcinoma. Int. J. Mol. Sci. 15, 15011\u201315025 (2014).","journal-title":"Int. J. Mol. Sci."},{"key":"4266_CR31","doi-asserted-by":"publisher","first-page":"951636","DOI":"10.3389\/fmolb.2022.951636","volume":"9","author":"Z Zhao","year":"2022","unstructured":"Z. Zhao et al., Prognostic and immunotherapeutic significance of mannose receptor C type II in 33 cancers: an integrated analysis. Front. Mol. Biosci. 9, 951636 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"4266_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1089\/thy.2011.0169","volume":"22","author":"NB Prasad","year":"2012","unstructured":"N.B. Prasad et al., Three-gene molecular diagnostic model for thyroid cancer. Thyroid 22, 275\u2013284 (2012).","journal-title":"Thyroid"},{"key":"4266_CR33","doi-asserted-by":"publisher","first-page":"2130229","DOI":"10.1155\/2021\/2130229","volume":"2021","author":"Y Xin","year":"2021","unstructured":"Y. Xin et al., Trefoil factor 3 inhibits thyroid cancer cell progression related to IL-6\/JAK\/STAT3 signaling pathway. Evidence Based Complement. Altern. Med. 2021, 2130229 (2021).","journal-title":"Evidence Based Complement. Altern. Med."},{"key":"4266_CR34","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1056\/NEJMoa021736","volume":"347","author":"C Phornphutkul","year":"2002","unstructured":"C. Phornphutkul et al., Natural history of alkaptonuria. N. Engl. J. Med. 347, 2111\u20132121 (2002).","journal-title":"N. Engl. J. Med."},{"key":"4266_CR35","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2174\/156800906778742442","volume":"6","author":"M Nakamura","year":"2006","unstructured":"M. Nakamura et al., Adrenomedullin:: a tumor progression factor via angiogenic control. Curr. Cancer Drug. Targets 6, 635\u2013643 (2006).","journal-title":"Curr. Cancer Drug. Targets"},{"key":"4266_CR36","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/bjc.2011.578","volume":"106","author":"S Karger","year":"2012","unstructured":"S. Karger et al., ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours. Br. J. Cancer 106, 562\u2013568 (2012).","journal-title":"Br. J. Cancer"},{"key":"4266_CR37","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/PAI.0000000000000637","volume":"27","author":"I Samija","year":"2019","unstructured":"I. Samija et al., HMGA2 gene expression in fine-needle aspiration samples of thyroid nodules as a marker for preoperative diagnosis of thyroid cancer. Appl. Immunohistochem. Mol. Morphol. 27, 471\u2013476 (2019).","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"4266_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6154-7","volume":"19","author":"SE Titov","year":"2019","unstructured":"S.E. Titov et al., Combined quantitation of HMGA2 mRNA, microRNAs, and mitochondrial-DNA content enables the identification and typing of thyroid tumors in fine-needle aspiration smears. BMC Cancer 19, 1010 (2019).","journal-title":"BMC Cancer"},{"key":"4266_CR39","doi-asserted-by":"publisher","first-page":"821855","DOI":"10.3389\/fcell.2022.821855","volume":"10","author":"T Holm","year":"2022","unstructured":"T. Holm et al., Targeting autophagy in thyroid cancer: EMT, apoptosis, and cancer stem cells. Front. Cell. Dev. Biol. 10, 821855 (2022).","journal-title":"Front. Cell. Dev. Biol."},{"key":"4266_CR40","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1385\/EP:15:4:329","volume":"15","author":"S Rezk","year":"2004","unstructured":"S. Rezk et al., \u03b2-catenin expression in thyroid follicular lesions: potential role in nuclear envelope changes in papillary carcinomas. Endocr. Pathol. 15, 329\u2013337 (2004).","journal-title":"Endocr. Pathol."},{"key":"4266_CR41","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s10517-016-3397-z","volume":"161","author":"AV Isaeva","year":"2016","unstructured":"A.V. Isaeva et al., Comparative evaluation of \u03b2-catenin and E-cadherin expression in liquid aspiration biopsy specimens of thyroid nodules. Bull. Exp. Biol. Med. 161, 288\u2013291 (2016).","journal-title":"Bull. Exp. Biol. Med."},{"key":"4266_CR42","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/1535-7163.MCT-13-0187","volume":"13","author":"Y Zhou","year":"2014","unstructured":"Y. Zhou et al., Off-target effects of c-MET inhibitors on thyroid cancer cells. Mol. Cancer Ther. 13, 134\u2013143 (2014).","journal-title":"Mol. Cancer Ther."},{"key":"4266_CR43","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1200\/JCO.2012.48.4659","volume":"31","author":"R Elisei","year":"2013","unstructured":"R. Elisei et al., Cabozantinib in progressive medullary thyroid cancer. J. Clin. Oncol. 31, 3639 (2013).","journal-title":"J. Clin. Oncol."},{"key":"4266_CR44","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/PAI.0000000000000332","volume":"25","author":"H Liu","year":"2017","unstructured":"H. Liu, J. Shi, F. Lin, The potential diagnostic utility of TROP-2 in thyroid neoplasms. Appl. Immunohistochem. Mol. Morphol. 25, 525\u2013533 (2017).","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"4266_CR45","first-page":"501","volume":"6","author":"L Naldini","year":"1991","unstructured":"L. Naldini et al., Hepatocyte growth-factor (HGF) stimulates the tyrosine kinase-activity of the receptor encoed by the proto-oncogene c-MET. Oncogene 6, 501\u2013504 (1991).","journal-title":"Oncogene"},{"key":"4266_CR46","first-page":"5740","volume":"17","author":"Y-H Kuo","year":"2019","unstructured":"Y.-H. Kuo et al., Expression of prothymosin in lung cancer is associated with squamous cell carcinoma and smoking. Oncol. Lett. 17, 5740\u20135746 (2019).","journal-title":"Oncol. Lett."},{"key":"4266_CR47","doi-asserted-by":"publisher","first-page":"9504","DOI":"10.1073\/pnas.90.20.9504","volume":"90","author":"OE Tsitsiloni","year":"1993","unstructured":"O.E. Tsitsiloni et al., Expression of alpha-thymosins in human tissues in normal and abnormal growth. Proc. Natl Acad. Sci. USA 90, 9504\u20139507 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4266_CR48","first-page":"57","volume":"54","author":"KP Letsas","year":"2007","unstructured":"K.P. Letsas et al., Fine-needle aspiration biopsy-RT-PCR expression analysis of prothymosin \u03b1 and parathymosin in thyroid: novel proliferation markers?. Neoplasma 54, 57\u201361 (2007).","journal-title":"Neoplasma"},{"key":"4266_CR49","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","volume":"25","author":"K Nemeth","year":"2024","unstructured":"K. Nemeth et al., Non-coding RNAs in disease: from mechanisms to therapeutics. Nat. Rev. Genet. 25, 211\u2013232 (2024).","journal-title":"Nat. Rev. Genet."},{"key":"4266_CR50","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrg2290","volume":"9","author":"W Filipowicz","year":"2008","unstructured":"W. Filipowicz, S.N. Bhattacharyya, N. Sonenberg, Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat. Rev. Genet. 9, 102\u2013114 (2008).","journal-title":"Nat. Rev. Genet."},{"key":"4266_CR51","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O\u2019Brien","year":"2018","unstructured":"J. O\u2019Brien et al., Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front. Endocrinol. 9, 402 (2018).","journal-title":"Front. Endocrinol."},{"key":"4266_CR52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3233\/CBM-140431","volume":"15","author":"M Sun","year":"2015","unstructured":"M. Sun et al., Associations of miR-146a and miR-146b expression and clinical characteristics in papillary thyroid carcinoma. Cancer Biomark. 15, 33\u201340 (2015).","journal-title":"Cancer Biomark."},{"key":"4266_CR53","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3390\/cancers13040632","volume":"13","author":"J-L Park","year":"2021","unstructured":"J.-L. Park et al., MicroRNA profile for diagnostic and prognostic biomarkers in thyroid cancer. Cancers 13, 632 (2021).","journal-title":"Cancers"},{"key":"4266_CR54","doi-asserted-by":"publisher","unstructured":"M.-R. Mahmoudian-Sani, et al, Diagnostic value of the candidate microRNAs in thyroid fine-needle aspiration biopsy (FNAB) samples. Horm. Mol. Biol. Clin. Investig. 41, (2020). https:\/\/doi.org\/10.1515\/hmbci-2019-0027","DOI":"10.1515\/hmbci-2019-0027"},{"key":"4266_CR55","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/09674845.2017.1347336","volume":"75","author":"F Yang","year":"2018","unstructured":"F. Yang et al., miR-146b measurement in FNA to distinguish papillary thyroid cancer from benign thyroid masses. Br. J. Biomed. Sci. 75, 43\u201345 (2018).","journal-title":"Br. J. Biomed. Sci."},{"key":"4266_CR56","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1158\/1078-0432.CCR-11-2487","volume":"18","author":"XM Keutgen","year":"2012","unstructured":"X.M. Keutgen et al., A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration. Clin. Cancer Res. 18, 2032\u20132038 (2012).","journal-title":"Clin. Cancer Res."},{"key":"4266_CR57","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s12020-020-02271-y","volume":"68","author":"M Sponziello","year":"2020","unstructured":"M. Sponziello et al., Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodules. Endocrine 68, 458\u2013465 (2020).","journal-title":"Endocrine"},{"key":"4266_CR58","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3390\/biomedicines11051473","volume":"11","author":"SAA Lukyanov","year":"2023","unstructured":"S.A.A. Lukyanov et al., New opportunities for preoperative diagnosis of medullary thyroid carcinoma. Biomedicines 11, 1473 (2023).","journal-title":"Biomedicines"},{"key":"4266_CR59","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s40618-018-0880-6","volume":"42","author":"MG Castagna","year":"2019","unstructured":"M.G. Castagna et al., MicroRNA expression profile of thyroid nodules in fine-needle aspiration cytology: a confirmatory series. J. Endocrinol. Invest. 42, 97\u2013100 (2019).","journal-title":"J. Endocrinol. Invest."},{"key":"4266_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1917-2","volume":"15","author":"F Panebianco","year":"2015","unstructured":"F. Panebianco et al., The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management. BMC Cancer 15, 918 (2015).","journal-title":"BMC Cancer"},{"key":"4266_CR61","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1089\/gtmb.2015.0062","volume":"19","author":"YZ Igci","year":"2015","unstructured":"Y.Z. Igci et al., Expression levels of miR-30a-5p in papillary thyroid carcinoma: a comparison between serum and fine needle aspiration biopsy samples. Genet. Test. Mol. Biomark. 19, 418\u2013423 (2015).","journal-title":"Genet. Test. Mol. Biomark."},{"key":"4266_CR62","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1210\/jc.2012-2694","volume":"98","author":"M Dettmer","year":"2013","unstructured":"M. Dettmer et al., MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas. J. Clin. Endocrinol. Metab. 98, E1\u2013E7 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4266_CR63","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s12020-016-1021-7","volume":"54","author":"T Stokowy","year":"2016","unstructured":"T. Stokowy et al., Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity. Endocrine 54, 440\u2013447 (2016).","journal-title":"Endocrine"},{"key":"4266_CR64","first-page":"2114","volume":"24","author":"ZW Lu","year":"2019","unstructured":"Z.W. Lu et al., MicroRNA-15 regulates the proliferation, migration and invasion of thyroid cancer cells by targeting Bcl-2. J. Buon. 24, 2114\u20132119 (2019).","journal-title":"J. Buon."},{"key":"4266_CR65","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3390\/genes15030389","volume":"15","author":"MD Matos","year":"2024","unstructured":"M.D. Matos et al., Cyto-histological profile of microRNAs as diagnostic biomarkers in differentiated thyroid carcinomas. Genes 15, 389 (2024).","journal-title":"Genes"},{"key":"4266_CR66","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/thy.2011.0313","volume":"22","author":"M Kitano","year":"2012","unstructured":"M. Kitano et al., Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples. Thyroid 22, 285\u2013291 (2012).","journal-title":"Thyroid"},{"key":"4266_CR67","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1002\/cncr.26587","volume":"118","author":"MR Vriens","year":"2012","unstructured":"M.R. Vriens et al., MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer. Cancer 118, 3426\u20133432 (2012).","journal-title":"Cancer"},{"key":"4266_CR68","doi-asserted-by":"publisher","first-page":"5573","DOI":"10.3390\/ijms20225573","volume":"20","author":"X Zhang","year":"2019","unstructured":"X. Zhang et al., Mechanisms and functions of long non-coding RNAs at multiple regulatory levels. Int. J. Mol. Sci. 20, 5573 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"4266_CR69","doi-asserted-by":"publisher","first-page":"e00206","DOI":"10.1128\/mBio.00206-10","volume":"1","author":"X Peng","year":"2010","unstructured":"X. Peng et al., Unique signatures of long noncoding RNA expression in response to virus infection and altered innate immune signaling. mBio 1, e00206 (2010).","journal-title":"mBio"},{"key":"4266_CR70","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41580-021-00330-4","volume":"22","author":"L Statello","year":"2021","unstructured":"L. Statello et al., Gene regulation by long non-coding RNAs and its biological functions. Nat. Rev. Mol. Cell Biol. 22, 159\u2013159 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"4266_CR71","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"D. Hanahan, R.A. Weinberg, The hallmarks of cancer. Cell 100, 57\u201370 (2000).","journal-title":"Cell"},{"key":"4266_CR72","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.3390\/cells11162517","volume":"11","author":"R Nadhan","year":"2022","unstructured":"R. Nadhan et al., Signaling by LncRNAs: structure, cellular homeostasis, and disease pathology. Cells 11, 2517 (2022).","journal-title":"Cells"},{"key":"4266_CR73","doi-asserted-by":"publisher","first-page":"924409","DOI":"10.3389\/fonc.2022.924409","volume":"12","author":"D Kim","year":"2022","unstructured":"D. Kim et al., Use of long non-coding RNAs for the molecular diagnosis of papillary thyroid cancer. Front. Oncol. 12, 924409 (2022).","journal-title":"Front. Oncol."},{"key":"4266_CR74","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/1440-1681.13229","volume":"47","author":"Y Zhou","year":"2020","unstructured":"Y. Zhou et al., LRRC52-AS1 is associated with clinical progression and regulates cell migration and invasion in papillary thyroid cancer. Clin. Exp. Pharmacol. Physiol. 47, 696\u2013702 (2020).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"4266_CR75","doi-asserted-by":"publisher","first-page":"e35542","DOI":"10.1097\/MD.0000000000035542","volume":"102","author":"J Xu","year":"2023","unstructured":"J. Xu et al., Significance of LINC02082 and LOC105369812 in differentiating papillary thyroid cancer from benign nodules. Medicine 102, e35542 (2023).","journal-title":"Medicine"},{"key":"4266_CR76","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s13577-019-00242-8","volume":"32","author":"Y Wang","year":"2019","unstructured":"Y. Wang et al., The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines. Hum. Cell 32, 334\u2013342 (2019).","journal-title":"Hum. Cell"},{"key":"4266_CR77","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"H. Davies et al., Mutations of the BRAF gene in human cancer. Nature 417, 949\u2013954 (2002).","journal-title":"Nature"},{"key":"4266_CR78","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","volume":"138","author":"P Gupta","year":"2009","unstructured":"P. Gupta et al., Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138, 645\u2013659 (2009).","journal-title":"Cell"},{"key":"4266_CR79","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.cell.2020.09.047","volume":"183","author":"A Palazzo","year":"2020","unstructured":"A. Palazzo, E. Koonin, Functional long non-coding RNAs evolve from junk transcripts. Cell 183, 1151\u20131161 (2020).","journal-title":"Cell"},{"key":"4266_CR80","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/cen.14400","volume":"94","author":"O Ronen","year":"2021","unstructured":"O. Ronen, M. Oichman, National differences in cost analysis of Afirma Genomic sequencing classifier. Clin. Endocrinol. 94, 717\u2013724 (2021).","journal-title":"Clin. Endocrinol."},{"key":"4266_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-15342-z","volume":"12","author":"N Xi","year":"2022","unstructured":"N. Xi, L. Wang, C. Yang, Improving the diagnosis of thyroid cancer by machine learning and clinical data. Sci. Rep. 12, 11143 (2022).","journal-title":"Sci. Rep."},{"key":"4266_CR82","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/MED.0000000000000557","volume":"27","author":"J Thomas","year":"2020","unstructured":"J. Thomas, G. Ledger, C. Mamillapalli, Use of artificial intelligence and machine learning for estimating malignancy risk of thyroid nodules. Curr. Opin. Endocrinol. Diabetes Obes. 27, 345\u2013350 (2020).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"4266_CR83","doi-asserted-by":"publisher","first-page":"1366687","DOI":"10.3389\/fendo.2024.1366687","volume":"15","author":"Y Cao","year":"2024","unstructured":"Y. Cao et al., Optimizing thyroid AUS nodules malignancy prediction: a comprehensive study of logistic regression and machine learning models. Front. Endocrinol. 15, 1366687 (2024).","journal-title":"Front. Endocrinol."},{"key":"4266_CR84","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1089\/thy.2019.0278","volume":"29","author":"W Goldner","year":"2019","unstructured":"W. Goldner et al., Molecular variants and their risks for malignancy in cytologically indeterminate thyroid nodules. Thyroid 29, 1594\u20131605 (2019).","journal-title":"Thyroid"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04266-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04266-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04266-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T15:42:49Z","timestamp":1757173369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04266-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":84,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["4266"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04266-z","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}